Why the world shouldn’t dismiss North Korea’s COVID-19 vaccine trials
North Korea's increased investment and emphasis on research means COVID-19 clinical trials might actually be underway
On July 18, North Korea announced that a domestically produced COVID-19 vaccine entered clinical trials, joining the global race to develop a cure for a virus that has already killed at least 650,000 people worldwide.
An otherwise quiet North Korean state website, Mirae, first published the report, which was then quickly picked up by South Korean media and even CNN. The New York Times went so far as to add the North Korean clinical trial to its vaccine tracker.
Nevertheless, news media was quick to stress doubt that the DPRK had the funds or expertise to develop
- 01Hope is not lost: President Biden might actually make progress on North Korea
- 02What North Korea can do right now to stave off a full-blown economic crisis
- 03North Korea upgrades security at Kim Jong Un’s giant Pyongyang mansion complex
- 04At least 14 North Korean ships disguise themselves in international waters
- 05October surprise? What to expect from North Korea ahead of the 2020 US election
- 06How South Korea’s entry into the Indo Pacific initiative will impact North Korea
- 07How Kim’s call for typhoon help exploits cheap labor and builds political unity
- 08North Korean moderates need their power back — or nuclear talks won’t succeed